Business Australia

Home Finance & Banking Stopping Private Equity’s Debt Trap

Stopping Private Equity’s Debt Trap

adminSeptember 17, 20263 Mins read1

Across nearly every corner of American medicine — dentistry, dermatology, emergency staffing, hospitals, hospice, oncology, women’s health — a familiar pattern has repeated itself. A private equity firm acquires a chain of practices or a hospital system, finances the deal with debt placed on the target’s own balance sheet, often extracts value through dividend recapitalizations or sale-leaseback transactions, and then watches as interest payments and rent obligations outpace the clinical business’s ability to generate cash. The result, in case after case, is Chapter 11, Chapter 7, or a distressed out-of-court restructuring that hands equity to lenders.

Stop Corporate Takeovers of Physicians Act

This week, Senators Elizabeth Warren, Jeff Merkley, and Ron Wyden, together with Representatives Alexandria Ocasio-Cortez, Val Hoyle, and Suhas Subramanyam introduced the Stop Corporate Takeovers of Physicians Act. The act establishes a federal framework to ban the corporate practice of medicine (CPOM).

The key provisions include:

Ban on Corporate Ownership: Prohibits private equity funds, health insurance companies, and other for-profit corporations from directly or indirectly owning, operating, or controlling medical practices.
Closes the MSO / “Friendly Physician” Loophole: Closes a common legal workaround where corporate firms set up Management Services Organizations (MSOs) and install a “captive” or “friendly” physician as nominal owner while controlling practice decisions behind the scenes.
Restricts Management Interference: Bars MSOs from dictating core administrative and operational functions that influence medical delivery, such as hiring/firing, work schedules, setting revenue targets, billing and coding practices, or dictating insurance contracting.
Requires Active Physician Ownership: Mandates that physician owners must be meaningfully engaged in providing clinical care within the state where the practice operates.
Protects Physician Independence: Prohibits corporate entities from interfering with clinical judgment and bans restrictive covenants—including non-compete, non-disclosure, and non-disparagement agreements—that prevent doctors from speaking out or practicing independently.
- Dermatology
- Ophthalmology
- Gastroenterology
- Emergency Medicine
- Orthopedics

Impact of Private Equity Ownership on Patient Care

Systematic reviews and health policy research including a comprehensive analysis in BMJ and studies from Harvard and UC Berkeley show mixed-to-negative impacts on patient care, including rises in death at PE sponsored hospitals.

Increased Costs: PE-backed practices typically charge higher prices, increase the use of high-margin procedures, and aggressively implement “surprise billing” or out-of-network pricing before federal regulations intervened.
Reduced Staffing & Overbooking: To generate rapid returns, firms often cut support staff (nurses, technicians) and push physicians to see more patients per hour, reducing spendable time per visit.
Upcoding & Revenue Maximization: Higher rates of billing for high-complexity diagnostic tests and procedure codes compared to independent practices.
Clinical Quality & Outcomes: While financial efficiency sometimes improves, empirical studies report no overall improvement in health outcomes, with several studies documenting higher rates of adverse events, complications, or readmissions following corporate restructuring.

Leveraged Debt in Private Equity Buyouts

Private Equity Sponsored Healthcare Debt Driven Bankruptcies

MRV

Private equity firms routinely make acquired practices take on debt.

The Leveraged Buyout (LBO) Model: Private equity acquisitions are structured such that 60% to 90% of the purchase price is financed through debt.
Who Holds the Debt? Crucially, this debt is placed on the financial books of the acquired medical group or health system, not the private equity parent firm.
Debt Load Expectations: In healthcare buyouts, debt levels frequently reach six times to seven times EBITDA (earnings before interest, taxes, depreciation, and amortization).
Operational Impact: To cover steep monthly debt payments (principal and interest), the medical practice is forced to prioritize short-term cash flow—often leading to dividend recapitalizations (where the practice borrows even more money to pay out immediate dividends to investors), severe cost-cutting, or insolvency. High debt burdens have directly contributed to major healthcare bankruptcies such as Steward Health Care.